Back | Next |
home / stock / teva / teva message board
Subject | By | Source | When |
---|---|---|---|
Have a look at this | Melia10 | investorshub | 04/19/2023 9:05:10 PM |
$TEVA we got news | Seeker213 | investorshub | 04/19/2023 10:17:54 AM |
Price trading last trade up | altruism | investorshub | 04/19/2023 5:39:47 AM |
The trading last up | WovenO2 | investorshub | 04/18/2023 5:32:37 PM |
$TEVA The now last trade up | weedtrader420 | investorshub | 04/17/2023 6:20:14 PM |
The trading last up | BottomBounce | investorshub | 04/17/2023 12:46:50 PM |
$TEVA got some short data | weedtrader420 | investorshub | 04/15/2023 10:22:07 AM |
$TEVA The gaining | JLS | investorshub | 04/15/2023 1:12:52 AM |
MomentumIts gaining | $treet $inatra | investorshub | 04/14/2023 4:41:47 PM |
The gaining up | JLS | investorshub | 04/14/2023 4:32:57 AM |
$TEVA What do you make of this? | JLS | investorshub | 04/13/2023 5:18:57 PM |
$TEVA Found an interesting article | FUNMAN | investorshub | 04/13/2023 10:58:49 AM |
we got news | JLS | investorshub | 04/12/2023 11:32:07 PM |
$TEVA MomentumIts gaining last up | JLS | investorshub | 04/11/2023 1:21:21 PM |
$TEVA Time for a bounce? | weedtrader420 | investorshub | 04/11/2023 9:46:05 AM |
$TEVA The now up | Zilla | investorshub | 04/10/2023 3:36:23 AM |
Thank you...It IS a great plan...Looking forward to | Zilla | investorshub | 02/26/2023 11:58:35 PM |
whytestocks: $TEVA News Article - Teva Announces Nationwide Opioids Settlement to Move Forward After | whytestocks | investorshangout | 01/09/2023 9:41:00 PM |
whytestocks: $TEVA News Article - Teva to Present at the 41st Annual J.P. Morgan Healthcare Conferen | whytestocks | investorshangout | 01/03/2023 9:40:47 PM |
Eli Lilly ordered to pay $176.5 mln to | midastouch017 | investorshub | 11/10/2022 1:23:13 PM |
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic (PK) profile based on the relevant PK modeling data Additional data include new Phase 3 RISE and SHINE analyses demonstrating no new or unexpected safet...
Nearly 98% of patients experience quality of life impact as a result of tardive dyskinesia (TD) including social, psychological, physical and recreational aspects of daily living Data highlight for the first time that TD has a multidimensional impact on patients including those with mild ...
U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 (VMAT2) inhibitor for effective and tolerable tardive dyskinesia (TD) and Huntington’s di...